Expression, regulation and clinical relevance of the ATPase inhibitory factor 1 in human cancers

M Sánchez-Aragó1, L Formentini, I Martínez-Reyes

  • 1Departamento de Biología Molecular, Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas-Universidad Autónoma de Madrid (CSIC-UAM), Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), ISCIII, Instituto de Investigación Hospital 12 de Octubre, Universidad Autónoma de Madrid, Madrid, Spain.

Oncogenesis
|April 24, 2013
PubMed

Insights

The ATPase inhibitory factor 1 (IF1) is overexpressed in most human carcinomas, promoting cancer cell survival and proliferation through aerobic glycolysis and reactive oxygen species (ROS) signaling. IF1 shows potential as a predictive marker and therapeutic target in cancer.

Area of Science:

  • Mitochondrial physiology
  • Cancer biology
  • Metabolic reprogramming

Background:

  • Inhibition of mitochondrial H(+)-adenosine triphosphate (ATP) synthase by ATPase inhibitory factor 1 (IF1) in colon cancer cells promotes aerobic glycolysis and reactive oxygen species (ROS) signaling, enhancing proliferation and survival.
  • Understanding IF1's role in various human carcinomas is crucial for identifying new therapeutic targets.

Purpose of the Study:

  • To investigate the expression, biological relevance, regulatory mechanisms, and clinical impact of IF1 in prevalent human carcinomas.
  • To explore IF1's role in metabolic reprogramming and cell survival across different cancer types.

Main Methods:

  • Analysis of IF1 expression in patient cohorts of colon, lung, breast, and ovarian carcinomas using various approaches.
  • Assessment of IF1's impact on aerobic glycolysis and ROS signaling in cancer cell lines.
  • Determination of IF1 protein half-life and investigation of post-transcriptional regulation.
  • Correlation of tumor IF1 expression with clinical outcomes in breast and colon cancer patients.

Main Results:

  • IF1 is highly overexpressed (>90%) in colon, lung, breast, and ovarian carcinomas, with negligible expression in corresponding normal tissues.
  • IF1 overexpression activates aerobic glycolysis and ROS signaling in lung, breast, and ovarian cancer cells, mimicking oligomycin effects.
  • IF1-mediated ROS signaling triggers adaptive responses to prevent cell death.
  • IF1 expression is regulated at post-transcriptional levels, with a short protein half-life (∼100 min) suggesting translational control or protein stabilization.
  • Tumor IF1 expression serves as a predictive marker for clinical outcome in breast and colon cancer patients.

Conclusions:

  • IF1 is a significantly overexpressed protein in major human carcinomas, playing a critical role in promoting cancer cell survival and proliferation.
  • Post-transcriptional regulation and protein stability are key drivers of IF1's function in metabolic reprogramming and survival.
  • IF1 represents a promising therapeutic target and a valuable predictive biomarker for cancer patient outcomes.

Related Concept Videos

ATP Synthase: Mechanism01:48

ATP Synthase: Mechanism

In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased ATP...
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
ATP Driven Pumps III: V-type Pumps01:30

ATP Driven Pumps III: V-type Pumps

V-type pumps are ATP-driven pumps found in the vacuolar membranes of plants, yeast, endosomal and lysosomal membranes of animal cells, plasma membranes of a few specialized eukaryotic cells, and some prokaryotes. They are also known as the V1Vo-ATPase, that couple ATP hydrolysis to transport protons against a concentration gradient.
The peripheral or cytosolic V1 domain with eight subunits is involved in ATP hydrolysis. The integral or transmembrane V0 domain containing at least five subunits...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
ATP Synthase: Structure01:18

ATP Synthase: Structure

ATP synthase or ATPase is among the most conserved proteins found in bacteria, mammals, and plants. This enzyme can catalyze a forward reaction in response to the electrochemical gradient, producing ATP from ADP and inorganic phosphate. ATP synthase can also work in a reverse direction by hydrolyzing ATP and generating an electrochemical gradient. Different forms of ATP synthases have evolved special features to meet the specific demands of the cell. Based on their specific feature, ATP...